{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:21:52Z","timestamp":1789017712228,"version":"build-2803163510"},"reference-count":18,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T00:00:00Z","timestamp":1225324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Inherited coagulopathies are bleeding disorders, which require treatment for life. Keeping an updated registry on these diseases is crucial for planning care, documenting prevalence of diseases and evaluating effectiveness of resources. We have analysed data from 26 treatment centres on coagulopathies in Brazil. Information included socio\u2010demographic data, diagnosis of coagulopathies, severity of haemophilias A and B, presence and quantification of inhibitors in haemophilia, type of von Willebrand disease (VWD) and infection status for viral diseases. On 1 July 2007, there were 10\u2003982 patients with inherited coagulopathies in Brazil, of which 6881 (62.7%) corresponded to haemophilia A, 1291 (11.7%) to haemophilia B, 2333 (21.2%) to VWD, 258 (2.4%) to other coagulopathies and 219 (2.0%) to undiagnosed bleeding disorders. Haemophilia A and B inhibitors were present in 9.9% and 1.9% of the patients, respectively. Human immunodeficiency virus infection was present is 6.5%, 4.8% and 1% of patients with haemophilia A, B and VWD, respectively. Hepatitis C virus infection was present in 34.9%, 29.7% and 12% of patients with haemophilia A, B and VWD, respectively. Infection by hepatitis B and human T\u2010cell leukemia\u2010lymphoma virus was also reported. This is the first report on the registry of patients with inherited coagulopathies in Brazil, supposed to be the third largest population of patients with haemophilia.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2008.01907.x","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T08:55:39Z","timestamp":1232009739000},"page":"142-149","source":"Crossref","is-referenced-by-count":28,"title":["Registry of inherited coagulopathies in Brazil: first report"],"prefix":"10.1111","volume":"15","author":[{"given":"S. M.","family":"REZENDE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"PINHEIRO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"CARAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"GENOVEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"BARCA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,15]]},"reference":[{"key":"e_1_2_8_2_2","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica. Available at:http:\/\/www.ibge.gov.br\/home\/(last accessed on 17 August2008)."},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01085.x"},{"key":"e_1_2_8_4_2","unstructured":"EvattBL.World Federation of Haemophilia Guide to Developing a National Patient Registry.World Federation of Hemophilia2005. Available at:http:\/\/www.wfh.org\/2\/docs\/Publications\/Diagnosis_and_Treatment\/Registry_Guide_2005.pdf(last accessed on 1 May 2008)."},{"key":"e_1_2_8_5_2","unstructured":"World Federation of Hemophilia Report on the Annual Global Survey 2006.World Federation of Haemophilia2007. Available at:http:\/\/www.wfh.org\/2\/4\/4_4_Link10_WFH\u2010News_Global\u2010Survey2006.htm."},{"key":"e_1_2_8_6_2","unstructured":"Relat\u00f3rio Estat\u00edstico do Cadastro de Coagulopatias Heredit\u00e1rias.Minist\u00e9rio da Sa\u00fade2002. Available at:http:\/\/www.anvisa.gov.br\/sangue\/p_hemofilia\/index.htm(last accessed on 1 May 2008)."},{"key":"e_1_2_8_7_2","unstructured":"Perfil das coagulopatias heredit\u00e1rias no Brasil 2007.Minist\u00e9rio da Sa\u00fade2008."},{"key":"e_1_2_8_8_2","doi-asserted-by":"crossref","unstructured":"WhiteGC RosendaalF AledortLMet\u00a0al.Scientific and Standardization Committee Communication: Definitions in Hemophilia. On behalf of the Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis 2000.","DOI":"10.1055\/s-0037-1615621"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I"},{"key":"e_1_2_8_10_2","unstructured":"Informa\u00e7\u00f5es sobre Sa\u00fade. Popula\u00e7\u00e3o Residente Brasil.Minist\u00e9rio da Sa\u00fade2008. Available athttp:\/\/tabnet.datasus.gov.br\/cgi\/deftohtm.exe?ibge\/cnv\/popuf.def(last accessed 01.07.2007)."},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01643.x"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01679.x"},{"key":"e_1_2_8_13_2","unstructured":"DolanG HayCRM. Annual Report 2006.United Kingdom Hemophilia Centre Doctors\u2019 Organization. Available at:http:\/\/www.robsoft.plus.com\/ukhcdo\/docs\/Annual%20Report%202007%20slides.pdf(last accessed on 1 May2008)."},{"key":"e_1_2_8_14_2","unstructured":"Canadian Hemophilia registry \u2013 Factor VIII.Haemophilia A2007. Available at:http:\/\/www.fhs.mcmaster.ca\/chr\/pdf\/08\/CHRVIII080417.pdf(last accessed on 1 May2008)."},{"key":"e_1_2_8_15_2","unstructured":"Bleeding and Clotting Disorders Surveillance.Department of Health and Human Services Center for Diseases Control and Prevention. Available at:http:\/\/www2.cdc.gov\/ncbddd\/htcweb\/UDC_Report\/UDC_Report.asp(last accessed on 1 May2008)."},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2003.00780.x"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90874-3"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01623.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068069"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2008.01907.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2008.01907.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T10:11:04Z","timestamp":1697364664000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2008.01907.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1365-2516.2008.01907.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01907.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}